Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1790

1.

Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell Transplantation.

Fujiwara S, Hattori N, Matsui T, Nakata A, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Kawaguchi Y, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Harada H, Nakamaki T.

Transplant Proc. 2019 Nov 13. pii: S0041-1345(19)30947-9. doi: 10.1016/j.transproceed.2019.08.044. [Epub ahead of print]

PMID:
31733801
2.

Multiple cerebral infarction diagnosed as Eosinophilic Granulomatosis with Polyangiitis by autopsy.

Hira K, Shimura H, Kamata R, Takanashi M, Hashizume A, Takahashi K, Sugiyama M, Izumi H, Hattori N, Urabe T.

BMC Neurol. 2019 Nov 15;19(1):288. doi: 10.1186/s12883-019-1515-z.

3.

Correction to: Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways.

Moro H, Hattori N, Nakamura Y, Kimura K, Imai T, Maeda M, Yashiro M, Ushijima T.

Gastric Cancer. 2019 Nov 15. doi: 10.1007/s10120-019-01013-y. [Epub ahead of print]

PMID:
31729582
4.

Durvalumab-Induced Organizing Pneumonia with a Diffuse Micronodular Pattern in a Lung Cancer Patient.

Yamasaki M, Taniwaki M, Kawamoto K, Matsumoto N, Hashimoto K, Nabeshima S, Ohashi N, Hattori N.

Am J Respir Crit Care Med. 2019 Nov 11. doi: 10.1164/rccm.201907-1310IM. [Epub ahead of print] No abstract available.

PMID:
31710509
5.

Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma.

Uno Y, Kanda M, Sato Y, Shimizu D, Umeda S, Hattori N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Nakayama G, Motoyama S, Koike M, Kodera Y.

Anticancer Res. 2019 Nov;39(11):6015-6023. doi: 10.21873/anticanres.13807.

PMID:
31704827
6.

Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer.

Endo M, Kanda M, Sawaki K, Shimizu D, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Yamada S, Koike M, Omae K, Kodera Y.

Anticancer Res. 2019 Nov;39(11):5903-5910. doi: 10.21873/anticanres.13794.

PMID:
31704814
7.

Omega-3 Polyunsaturated Fatty Acids and Stroke Burden.

Ueno Y, Miyamoto N, Yamashiro K, Tanaka R, Hattori N.

Int J Mol Sci. 2019 Nov 7;20(22). pii: E5549. doi: 10.3390/ijms20225549. Review.

8.

Evaluation of white matter microstructure in patients with Parkinson's disease using microscopic fractional anisotropy.

Ikenouchi Y, Kamagata K, Andica C, Hatano T, Ogawa T, Takeshige-Amano H, Kamiya K, Wada A, Suzuki M, Fujita S, Hagiwara A, Irie R, Hori M, Oyama G, Shimo Y, Umemura A, Hattori N, Aoki S.

Neuroradiology. 2019 Nov 4. doi: 10.1007/s00234-019-02301-1. [Epub ahead of print]

PMID:
31680195
9.

Comparative study of tacrolimus and short-term methotrexate: two-day versus three-day methotrexate as graft-versus-host-disease prophylaxis after umbilical cord blood transplantation in adults.

Hattori N, Saito B, Matsui T, Nakata A, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Fujiwara S, Kawaguchi Y, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Harada H, Nakamaki T.

Biol Blood Marrow Transplant. 2019 Oct 31. pii: S1083-8791(19)30704-9. doi: 10.1016/j.bbmt.2019.10.022. [Epub ahead of print]

PMID:
31678538
10.

Levodopa-Induced Hyperventilation Observed in a Parkinson's Disease Patient.

Hattori A, Tsunemi T, Shimada T, Nakagawa E, Hattori N.

Can J Neurol Sci. 2019 Oct 8:1-2. doi: 10.1017/cjn.2019.306. [Epub ahead of print] No abstract available.

PMID:
31657291
11.

Neuromyelitis optica spectrum disorder after treatment with pembrolizumab.

Shimada T, Hoshino Y, Tsunemi T, Hattori A, Nakagawa E, Yokoyama K, Hattori N.

Mult Scler Relat Disord. 2019 Oct 14;37:101447. doi: 10.1016/j.msard.2019.101447. [Epub ahead of print]

PMID:
31655267
12.

Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.

Kanda M, Koike M, Shimizu D, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Omae K, Yamada S, Nakayama G, Kodera Y.

Ann Surg Oncol. 2019 Oct 24. doi: 10.1245/s10434-019-07977-6. [Epub ahead of print]

PMID:
31650302
13.

MRI-based visualization of rTMS-induced cortical plasticity in the primary motor cortex.

Tamura K, Osada T, Ogawa A, Tanaka M, Suda A, Shimo Y, Hattori N, Kamagata K, Hori M, Aoki S, Shimizu T, Enomoto H, Hanajima R, Ugawa Y, Konishi S.

PLoS One. 2019 Oct 24;14(10):e0224175. doi: 10.1371/journal.pone.0224175. eCollection 2019.

14.

[Combination of Immunotherapy and Hyperthermia].

Kubota Y, Takeda T, Takeda T, Noda T, Hattori N, Nakamura K, Yasuda T, Hasegawa T, Yokoyama Y, Yamamoto H, Takeda H.

Gan To Kagaku Ryoho. 2019 Oct;46(10):1605-1607. Japanese.

PMID:
31631149
15.

Somnolence Preceded the Development of a Subthalamic Lesion in Neuromyelitis Optica Spectrum Disorder: A Case Report.

Daida K, Ogaki K, Hayashida A, Ando M, Yokoyama K, Noda K, Kanbayashi T, Hattori N, Okuma Y.

Intern Med. 2019 Oct 15. doi: 10.2169/internalmedicine.2947-19. [Epub ahead of print]

16.

Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus.

Kanda M, Koike M, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Yamada S, Omae K, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2019 Oct 11. doi: 10.1245/s10434-019-07914-7. [Epub ahead of print]

PMID:
31605344
17.

Mutations in CHCHD2 cause α-synuclein aggregation.

Ikeda A, Nishioka K, Meng H, Takanashi M, Inoshita T, Shiba-Fukushima K, Li Y, Yoshino H, Mori A, Okuzumi A, Yamaguchi A, Nonaka R, Izawa N, Ishikawa KI, Saiki H, Morita M, Hasegawa M, Hasegawa K, Elahi M, Funayama M, Okano H, Akamatsu W, Imai Y, Hattori N.

Hum Mol Genet. 2019 Oct 10. pii: ddz241. doi: 10.1093/hmg/ddz241. [Epub ahead of print]

PMID:
31600778
18.

Mutation analysis of LRP10 in Japanese patients with familial Parkinson's disease, progressive supranuclear palsy, and frontotemporal dementia.

Daida K, Nishioka K, Li Y, Yoshino H, Kikuchi A, Hasegawa T, Funayama M, Hattori N.

Neurobiol Aging. 2019 Sep 6. pii: S0197-4580(19)30309-4. doi: 10.1016/j.neurobiolaging.2019.08.030. [Epub ahead of print]

PMID:
31582232
19.

Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer.

Nakao S, Yamaguchi K, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Iwamoto H, Fujitaka K, Hamada H, Hattori N.

Anticancer Res. 2019 Oct;39(10):5725-5731. doi: 10.21873/anticanres.13773.

PMID:
31570474
20.

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.

Mori A, Ishikawa KI, Saiki S, Hatano T, Oji Y, Okuzumi A, Fujimaki M, Koinuma T, Ueno SI, Imamichi Y, Hattori N.

PLoS One. 2019 Sep 27;14(9):e0223113. doi: 10.1371/journal.pone.0223113. eCollection 2019.

21.

Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways.

Moro H, Hattori N, Nakamura Y, Kimura K, Imai T, Maeda M, Yashiro M, Ushijima T.

Gastric Cancer. 2019 Sep 25. doi: 10.1007/s10120-019-01010-1. [Epub ahead of print] Erratum in: Gastric Cancer. 2019 Nov 15;:.

PMID:
31555951
22.

Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling.

Mori A, Hatano T, Inoshita T, Shiba-Fukushima K, Koinuma T, Meng H, Kubo SI, Spratt S, Cui C, Yamashita C, Miki Y, Yamamoto K, Hirabayashi T, Murakami M, Takahashi Y, Shindou H, Nonaka T, Hasegawa M, Okuzumi A, Imai Y, Hattori N.

Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20689-20699. doi: 10.1073/pnas.1902958116. Epub 2019 Sep 23.

23.

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II).

Hattori N, Nakayama G, Uehara K, Aiba T, Ishigure K, Sakamoto E, Tojima Y, Kanda M, Kobayashi D, Tanaka C, Yamada S, Koike M, Fujiwara M, Nagino M, Kodera Y.

Int J Clin Oncol. 2019 Sep 21. doi: 10.1007/s10147-019-01546-3. [Epub ahead of print]

PMID:
31542847
24.

Metabolomic analysis revealed mitochondrial dysfunction and aberrant choline metabolism in MPP+-exposed SH-SY5Y cells.

Amo T, Oji Y, Saiki S, Hattori N.

Biochem Biophys Res Commun. 2019 Nov 12;519(3):540-546. doi: 10.1016/j.bbrc.2019.09.031. Epub 2019 Sep 16.

PMID:
31537380
25.

MR g-ratio-weighted connectome analysis in patients with multiple sclerosis.

Kamagata K, Zalesky A, Yokoyama K, Andica C, Hagiwara A, Shimoji K, Kumamaru KK, Takemura MY, Hoshino Y, Kamiya K, Hori M, Pantelis C, Hattori N, Aoki S.

Sci Rep. 2019 Sep 18;9(1):13522. doi: 10.1038/s41598-019-50025-2.

26.

Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer.

Nakanishi Y, Masuda T, Yamaguchi K, Sakamoto S, Horimasu Y, Mimae T, Nakashima T, Miyamoto S, Tsutani Y, Iwamoto H, Fujitaka K, Miyata Y, Hamada H, Okada M, Hattori N.

Int J Clin Oncol. 2019 Sep 17. doi: 10.1007/s10147-019-01539-2. [Epub ahead of print]

PMID:
31531785
27.

Skeletal muscle function and need for long-term care of urban elderly people in Japan (the Bunkyo Health Study): a prospective cohort study.

Someya Y, Tamura Y, Kaga H, Nojiri S, Shimada K, Daida H, Ishijima M, Kaneko K, Aoki S, Miida T, Hirayama S, Konishi S, Hattori N, Motoi Y, Naito H, Kawamori R, Watada H.

BMJ Open. 2019 Sep 17;9(9):e031584. doi: 10.1136/bmjopen-2019-031584.

28.

Procedures for the diagnosis of macro-follicle stimulating hormone (FSH) in a patient with high serum FSH concentrations.

Chihara K, Hattori N, Matsuda T, Murasawa S, Daimon M, Shimatsu A.

Clin Chem Lab Med. 2019 Sep 17. pii: /j/cclm.ahead-of-print/cclm-2019-0846/cclm-2019-0846.xml. doi: 10.1515/cclm-2019-0846. [Epub ahead of print] No abstract available.

PMID:
31525153
29.

White Matter Abnormalities in Multiple Sclerosis Evaluated by Quantitative Synthetic MRI, Diffusion Tensor Imaging, and Neurite Orientation Dispersion and Density Imaging.

Hagiwara A, Kamagata K, Shimoji K, Yokoyama K, Andica C, Hori M, Fujita S, Maekawa T, Irie R, Akashi T, Wada A, Suzuki M, Abe O, Hattori N, Aoki S.

AJNR Am J Neuroradiol. 2019 Oct;40(10):1642-1648. doi: 10.3174/ajnr.A6209. Epub 2019 Sep 12.

PMID:
31515218
30.

A Case of New-onset Refractory Status Epilepticus Involving the Limbic System, Spinal Cord, and Peripheral Nerves.

Daida K, Nishioka K, Takanashi M, Kobayashi M, Yoshikawa K, Kusunoki S, Yokoyama K, Hattori N.

Intern Med. 2019 Sep 11. doi: 10.2169/internalmedicine.3510-19. [Epub ahead of print]

31.

Temporal Features of Muscle Synergies in Sit-to-Stand Motion Reflect the Motor Impairment of Post-Stroke Patients.

Yang N, An Q, Kogami H, Yamakawa H, Tamura Y, Takahashi K, Kinomoto M, Yamasaki H, Itkonen M, Shibata-Alnajjar F, Shimoda S, Hattori N, Fujii T, Otomune H, Miyai I, Yamashita A, Asama H.

IEEE Trans Neural Syst Rehabil Eng. 2019 Oct;27(10):2118-2127. doi: 10.1109/TNSRE.2019.2939193. Epub 2019 Sep 4.

PMID:
31494552
32.

Pulmonary cryptococcosis mimicking lung cancer.

Taniwaki M, Yamasaki M, Ishikawa N, Kawamoto K, Hattori N.

Lancet Infect Dis. 2019 Sep;19(9):1033. doi: 10.1016/S1473-3099(19)30278-6. No abstract available.

PMID:
31478508
33.

Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson's Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS).

Sato K, Aita N, Hokari Y, Kitahara E, Tani M, Izawa N, Hatori K, Nakamura R, Sasaki F, Sekimoto S, Jo T, Oyama G, Hatano T, Shimo Y, Iwamuro H, Umemura A, Hattori N, Fujiwara T.

Parkinsons Dis. 2019 Aug 4;2019:7104071. doi: 10.1155/2019/7104071. eCollection 2019.

34.

Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC.

Ohue Y, Kurose K, Karasaki T, Isobe M, Yamaoka T, Futami J, Irei I, Masuda T, Fukuda M, Kinoshita A, Matsushita H, Shimizu K, Nakata M, Hattori N, Yamaguchi H, Fukuda M, Nozawa R, Kakimi K, Oka M.

J Thorac Oncol. 2019 Aug 23. pii: S1556-0864(19)30691-4. doi: 10.1016/j.jtho.2019.08.008. [Epub ahead of print]

35.

Clinical Characterization of Definite Autoimmune Limbic Encephalitis: A 30-case Series.

Shojima Y, Nishioka K, Watanabe M, Jo T, Tanaka K, Takashima H, Noda K, Okuma Y, Urabe T, Yokoyama K, Hattori N.

Intern Med. 2019 Aug 21. doi: 10.2169/internalmedicine.3029-19. [Epub ahead of print]

36.

Neuroprotective effects of memantine via enhancement of autophagy.

Hirano K, Fujimaki M, Sasazawa Y, Yamaguchi A, Ishikawa KI, Miyamoto K, Souma S, Furuya N, Imamichi Y, Yamada D, Saya H, Akamatsu W, Saiki S, Hattori N.

Biochem Biophys Res Commun. 2019 Oct 8;518(1):161-170. doi: 10.1016/j.bbrc.2019.08.025. Epub 2019 Aug 17.

PMID:
31431260
37.

Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapy.

Yoshiya T, Mimae T, Ito M, Sasada S, Tsutani Y, Satoh K, Masuda T, Miyata Y, Hattori N, Okada M.

Invest New Drugs. 2019 Aug 19. doi: 10.1007/s10637-019-00836-x. [Epub ahead of print]

PMID:
31428894
38.

C-C Motif Chemokine Ligand 15 May Be a Useful Biomarker for Predicting the Prognosis of Patients with Chronic Hypersensitivity Pneumonitis.

Watanabe M, Horimasu Y, Iwamoto H, Yamaguchi K, Sakamoto S, Masuda T, Nakashima T, Miyamoto S, Ohshimo S, Fujitaka K, Hamada H, Kohno N, Hattori N.

Respiration. 2019;98(3):212-220. doi: 10.1159/000500576. Epub 2019 Aug 15.

39.

Platinum-doublet chemotherapy followed by pembrolizumab therapy for lung cancer with lymphangitis carcinomatosa mimicking interstitial pneumonitis: A case report.

Yamasaki M, Funaishi K, Kawamoto K, Matsumoto Y, Matsumoto N, Taniwaki M, Ohashi N, Hattori N.

Medicine (Baltimore). 2019 Aug;98(33):e16834. doi: 10.1097/MD.0000000000016834.

40.

[EVALUATION OF A MOTOR AND SENSORY DISTURBANCE QUESTIONNAIRE FOR PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS].

Ueki Y, Oshikata C, Asai Y, Kaneko T, Hattori N, Tsurikisawa N.

Arerugi. 2019;68(7):857-868. doi: 10.15036/arerugi.68.857. Japanese.

PMID:
31406082
41.

Convolutional neural network-based segmentation can help in assessing the substantia nigra in neuromelanin MRI.

Le Berre A, Kamagata K, Otsuka Y, Andica C, Hatano T, Saccenti L, Ogawa T, Takeshige-Amano H, Wada A, Suzuki M, Hagiwara A, Irie R, Hori M, Oyama G, Shimo Y, Umemura A, Hattori N, Aoki S.

Neuroradiology. 2019 Dec;61(12):1387-1395. doi: 10.1007/s00234-019-02279-w. Epub 2019 Aug 10.

PMID:
31401723
42.

Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia.

Nakamura T, Sekimoto S, Oyama G, Shimo Y, Hattori N, Kajimoto H.

PLoS One. 2019 Aug 8;14(8):e0219758. doi: 10.1371/journal.pone.0219758. eCollection 2019.

43.

Free-Water Imaging in White and Gray Matter in Parkinson's Disease.

Andica C, Kamagata K, Hatano T, Saito A, Uchida W, Ogawa T, Takeshige-Amano H, Zalesky A, Wada A, Suzuki M, Hagiwara A, Irie R, Hori M, Kumamaru KK, Oyama G, Shimo Y, Umemura A, Pantelis C, Hattori N, Aoki S.

Cells. 2019 Aug 5;8(8). pii: E839. doi: 10.3390/cells8080839.

44.

Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.

Kamo H, Hatano T, Kanai K, Aoki N, Kamiyama D, Yokoyama K, Takanashi M, Yamashita Y, Shimo Y, Hattori N.

BMC Neurol. 2019 Aug 5;19(1):184. doi: 10.1186/s12883-019-1416-1.

45.

Novel prodrugs of decitabine with greater metabolic stability and less toxicity.

Hattori N, Sako M, Kimura K, Iida N, Takeshima H, Nakata Y, Kono Y, Ushijima T.

Clin Epigenetics. 2019 Aug 1;11(1):111. doi: 10.1186/s13148-019-0709-y.

46.

[Indication for Deep Brain Stimulation].

Shimo Y, Umemura A, Hattori N.

Brain Nerve. 2019 Aug;71(8):885-892. doi: 10.11477/mf.1416201369. Review. Japanese.

PMID:
31346145
47.

Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis.

Kuwahara K, Ohba S, Nakae S, Hattori N, Pareira ES, Yamada S, Sasaki H, Abe M, Hasegawa M, Hirose Y.

Brain Tumor Pathol. 2019 Oct;36(4):135-143. doi: 10.1007/s10014-019-00348-9. Epub 2019 Jul 19.

PMID:
31324999
48.

Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.

Lee JS, Kanai K, Suzuki M, Kim WS, Yoo HS, Fu Y, Kim DK, Jung BC, Choi M, Oh KW, Li Y, Nakatani M, Nakazato T, Sekimoto S, Funayama M, Yoshino H, Kubo SI, Nishioka K, Sakai R, Ueyama M, Mochizuki H, Lee HJ, Sardi SP, Halliday GM, Nagai Y, Lee PH, Hattori N, Lee SJ.

Brain. 2019 Sep 1;142(9):2845-2859. doi: 10.1093/brain/awz205.

PMID:
31312839
49.

Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis.

Nishida Y, Takahashi YK, Kanai T, Nose Y, Ishibashi S, Sanjo N, Uzawa A, Oda F, Ozawa Y, Kuwabara S, Noguchi E, Suzuki S, Nakahara J, Suzuki N, Ogawa T, Yokoyama K, Hattori N, Konno S, Fujioka T, Kawaguchi N, Hatanaka Y, Sonoo M, Kaneko J, Ogino M, Nishiyama K, Nomura K, Yokota T.

Eur J Neurol. 2019 Jul 15. doi: 10.1111/ene.14039. [Epub ahead of print]

PMID:
31309642
50.

Protective Role of Levetiracetam Against Cognitive Impairment And Brain White Matter Damage in Mouse prolonged Cerebral Hypoperfusion.

Inaba T, Miyamoto N, Hira K, Ueno Y, Yamashiro K, Watanabe M, Shimada Y, Hattori N, Urabe T.

Neuroscience. 2019 Aug 21;414:255-264. doi: 10.1016/j.neuroscience.2019.07.015. Epub 2019 Jul 11.

PMID:
31302262

Supplemental Content

Loading ...
Support Center